Restoration of innate immune activation accelerates Th1-cell priming and protection following pulmonary mycobacterial infection

European Journal of Immunology

Volumn 44, Issue 5, 2014, Pages 1375-1386

  Lai, Rocky ^a   Jeyanathan, Mangalakumari ^a   Shaler, Christopher R ^a   Damjanovic, Daniela ^a   Khera, Amandeep ^a   Horvath, Carly ^a   Ashkar, Ali A ^a   Xing, Zhou ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

DCs; Delayed Th1 immunity; FimH; Mycobacterium; Tuberculosis

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 12; KERATINOCYTE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; BACTERIAL LOAD; CELL MIGRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RESPONSE; DENDRITIC CELL; INNATE IMMUNITY; LUNG TUBERCULOSIS; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; VACCINATION;

DCS; DELAYED TH1 IMMUNITY; FIMH; MYCOBACTERIUM; TUBERCULOSIS;

ANIMALS; DENDRITIC CELLS; IMMUNITY, INNATE; LUNG; LYMPH NODES; MICE; MICE, TRANSGENIC; MYCOBACTERIUM TUBERCULOSIS; TH1 CELLS; TIME FACTORS; TUBERCULOSIS, PULMONARY;

EID: 84899542466     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201344300     Document Type: Article

References (44)

1. WHO, Global Tuberculosis Report 2012. 2012.
2. Kendall, B. A. and Winthrop, K. L., Update on the epidemiology of pulmonary nontuberculous mycobacterial infections. Semin. Respir. Crit. Care Med. 2013. 34: 87-94.
3. Wolf, A. J., Linas, B., Trevejo-Nunez, G. J., Kincaid, E., Tamura, T., Takatsu, K. and Ernst, J. D., Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J. Immunol. 2007. 179: 2509-2519.
4. Guilliams, M., Lambrecht, B. N. and Hammad, H., Division of labor between lung dendritic cells and macrophages in the defense against pulmonary infections. Mucosal. Immunol. 2013. 6: 464-473.
5. Chackerian, A. A., Alt, J. M., Perera, T. V., Dascher, C. C. and Behar, S. M., Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. Infect. Immun. 2002. 70: 4501-4509.
6. Cooper, A. M. and Khader, S. A., The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol. Rev. 2008. 226: 191-204.
7. Cooper, A. M., Cell-mediated immune responses in tuberculosis. Ann. Rev. Immunol. 2009. 27: 393-422.
8. Wolf, A. J., Desvignes, L., Linas, B., Banaiee, N., Tamura, T., Takatsu, K. and Ernst, J. D., Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J. Exp. Med. 2008. 205: 105-115.
9. Reiley, W. W., Shafiani, S., Wittmer, S. T., Tucker-Heard, G., Moon, J. J., Jenkins, M. K. et al., Distinct functions of antigen-specific CD4 T cells during murine Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 2010. 107: 19408-19413.
10. Jeyanathan, M., McCormick, S., Lai, R., Afkhami, S., Shaler, C. R., Horvath, C. N., Damjanovic, D. et al., Pulmonary M. tuberculosis infection delays Th1 immunity via immunoadaptor DAP12-regulated IRAK-M and IL-10 expression in antigen-presenting cells. Mucosal. Immunol. 2013. Doi: 10.1038/mi.2013.86. [Epub ahead of print]
11. Friedman, H., Yamamoto, Y. and Klein, T. W., Legionella pneumophila pathogenesis and immunity. Semin. Pediatr. Infect. Dis. 2002. 13: 273-279.
12. Ordway, D., Henao-Tamayo, M., Smith, E., Shanley, C., Harton, M., Troudt, J., Bai, X. et al., Animal model of Mycobacterium abscessus lung infection. J. Leukoc. Biol. 2008. 83: 1502-1511.
13. Shaler, C. R., Horvath, C., Lai, R. and Xing, Z., Understanding delayed T-cell priming, lung recruitment, and airway luminal T-cell responses in host defense against pulmonary tuberculosis. Clin. Dev. Immunol. 2012. 2012: 628293.
14. Urdahl, K. B., Shafiani, S. and Ernst, J. D., Initiation and regulation of T-cell responses in tuberculosis. Mucosal. Immunol. 2011. 4: 288-293.
15. Divangahi, M., Desjardins, D., Nunes-Alves, C., Remold, H. G. and Behar, S. M., Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis. Nat. Immunol. 2010. 11: 751-758.
16. Blomgran, R., Desvignes, L., Briken, V. and Ernst, J. D., Mycobacterium tuberculosis inhibits neutrophil apoptosis, leading to delayed activation of naive CD4 T cells. Cell Host Microbe. 2012. 11: 81-90.
17. Redford, P. S., Boonstra, A., Read, S., Pitt, J., Graham, C., Stavropoulos, E., Bancroft, G. J. and O'Garra, A., Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung. Eur. J. Immunol. 2010. 40: 2200-2210.
18. Beisiegel, M., Kursar, M., Koch, M., Loddenkemper, C., Kuhlmann, S., Zedler, U., Staber, M. et al., Combination of host susceptibility and virulence of Mycobacterium tuberculosis determines dual role of nitric oxide in the protection and control of inflammation. J. Infect. Dis. 2009. 199: 1222-1232.
19. Horvath, C. N., Shaler, C. R., Jeyanathan, M., Zganiacz, A. and Xing, Z., Mechanisms of delayed anti-tuberculosis protection in the lung of parenteral BCG-vaccinated hosts: a critical role of airway luminal T cells. Mucosal. Immunol. 2012. 5: 420-431.
20. Fulton, S. A., Martin, T. D., Redline, R. W. and Henry Boom, W., Pulmonary immune responses during primary mycobacterium bovis-Calmette-Guerin bacillus infection in C57Bl/6 mice. Am. J. Respir. Cell Mol. Biol. 2000. 22: 333-343.
21. Pecora, N. D., Fulton, S. A., Reba, S. M., Drage, M. G., Simmons, D. P., Urankar-Nagy, N. J., Boom, W. H. and Harding, C. V., Mycobacterium bovis BCG decreases MHC-II expression in vivo on murine lung macrophages and dendritic cells during aerosol infection. Cell Immunol. 2009. 254: 94-104.
22. Fulton, S. A., Reba, S. M., Pai, R. K., Pennini, M., Torres, M., Harding, C. V. and Boom, W. H., Inhibition of major histocompatibility complex II expression and antigen processing in murine alveolar macrophages by Mycobacterium bovis BCG and the 19-kilodalton mycobacterial lipoprotein. Infect. Immun. 2004. 72: 2101-2110.
23. Rajaram, M. V., Ni, B., Morris, J. D., Brooks, M. N., Carlson, T. K., Bakthavachalu, B., Schoenberg, D. R. et al., Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b. Proc. Natl. Acad Sci. USA 2011. 108: 17408-17413.
24. Balboa, L., Romero, M. M., Yokobori, N., Schierloh, P., Geffner, L., Basile, J. I., Musella, R. M. et al., Mycobacterium tuberculosis impairs dendritic cell response by altering CD1b, DC-SIGN and MR profile. Immunol. Cell Biol. 2010. 88: 716-726.
25. McCormick, S., Shaler, C. R. and Xing, Z., Pulmonary mucosal dendritic cells in T-cell activation: implications for TB therapy. Expert. Rev. Respir. Med. 2011. 5: 75-85.
26. Ballesteros-Tato, A., Leon, B., Lund, F. E. and Randall, T. D., Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8(+) T cell responses to influenza. Nat. Immunol. 2010. 11: 216-224.
27. Steinhagen, F., Kinjo, T., Bode, C. and Klinman, D. M., TLR-based immune adjuvants. Vaccine 2011. 29: 3341-3355.
28. Abdul-Careem, M. F., Firoz Mian, M., Gillgrass, A. E., Chenoweth, M. J., Barra, N. G., Chan, T., Al-Garawi, A. A. et al., FimH, a TLR4 ligand, induces innate antiviral responses in the lung leading to protection against lethal influenza infection in mice. Antiviral. Res. 2011. 92: 346-355.
29. Khader, S. A., Partida-Sanchez, S., Bell, G., Jelley-Gibbs, D. M., Swain, S., Pearl, J. E., Ghilardi, N. et al., Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J. Exp. Med. 2006. 203: 1805-1815.
30. Russell, M. S., Iskandar, M., Mykytczuk, O. L., Nash, J. H., Krishnan, L. and Sad, S., A reduced antigen load in vivo, rather than weak inflammation, causes a substantial delay in CD8+ T cell priming against Mycobacterium bovis (bacillus Calmette-Guerin). J. Immunol. 2007. 179: 211-220.
31. Divangahi, M., Behar, S. M. and Remold, H., Dying to live: how the death modality of the infected macrophage affects immunity to tuberculosis. Adv. Exp. Med. Biol. 2013. 783: 103-120.
32. Divangahi, M., Chen, M., Gan, H., Desjardins, D., Hickman, T. T., Lee, D. M., Fortune, S. et al., Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat. Immunol. 2009. 10: 899-906.
33. Divangahi, M., Yang, T., Kugathasan, K., McCormick, S., Takenaka, S., Gaschler, G., Ashkar, A. et al., Critical negative regulation of type 1 T cell immunity and immunopathology by signaling adaptor DAP12 during intracellular infection. J. Immunol. 2007. 179: 4015-4026.
34. Myers, A. J., Marino, S., Kirschner, D. E. and Flynn, J. L., Inoculation dose of Mycobacterium tuberculosis does not influence priming of T cell responses in lymph nodes. J. Immunol. 2013. 190: 4707-4716.
35. Gonzalez-Perez, M., Marino-Ramirez, L., Parra-Lopez, C. A., Murcia, M. I., Marquina, B., Mata-Espinoza, D., Rodriguez-Miguez, Y. et al., Virulence and immune response induced by Mycobacterium avium complex strains in a model of progressive pulmonary tuberculosis and subcutaneous infection in BALB/c mice. Infect. Immun. 2013. 11: 4001-4012.
36. Arias, M. A., Jaramillo, G., Lopez, Y. P., Mejia, N., Mejia, C., Pantoja, A. E., Shattock, R. J. et al., Mycobacterium tuberculosis antigens specifically modulate CCR2 and MCP-1/CCL2 on lymphoid cells from human pulmonary hilar lymph nodes. J. Immunol. 2007. 179: 8381-8391.
37. Thompson, B. S., Chilton, P. M., Ward, J. R., Evans, J. T. and Mitchell, T. C., The low-toxicity versions of LPS, MPL adjuvant and RC529, are efficient adjuvants for CD4+ T cells. J. Leukoc. Biol. 2005. 78: 1273-1280.
38. Baxevanis, C. N., Voutsas, I. F. and Tsitsilonis, O. E., Toll-like receptor agonists: current status and future perspective on their utility as adjuvants in improving anticancer vaccination strategies. Immunotherapy 2013. 5: 497-511.
39. Ashkar, A. A., Mossman, K. L., Coombes, B. K., Gyles, C. L. and Mackenzie, R., FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling. PLoS Pathog. 2008. 4: e1000233.
40. Blomgran, R. and Ernst, J. D., Lung neutrophils facilitate activation of naive antigen-specific CD4+ T cells during Mycobacterium tuberculosis infection. J. Immunol. 2011. 186: 7110-7119.
41. Blomgran, R., Zheng, L. and Stendahl, O., Uropathogenic Escherichia coli triggers oxygen-dependent apoptosis in human neutrophils through the cooperative effect of type 1 fimbriae and lipopolysaccharide. Infect. Immun. 2004. 72: 4570-4578.
42. Leepiyasakulchai, C., Ignatowicz, L., Pawlowski, A., Kallenius, G. and Skold, M., Failure to recruit anti-inflammatory CD103+ dendritic cells and a diminished CD4+ Foxp3 +regulatory T cell pool in mice that display excessive lung inflammation and increased susceptibility to Mycobacterium tuberculosis. Infect. Immun. 2012. 80: 1128-1139.
43. Santosuosso, M., Zhang, X., McCormick, S., Wang, J., Hitt, M. and Xing, Z., Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen. J. Immunol. 2005. 174: 7986-7994.
44. Jeyanathan, M., Damjanovic, D., Shaler, C. R., Lai, R., Wortzman, M., Yin, C., Zganiacz, A. et al., Differentially imprinted innate immunity by mucosal boost vaccination determines antituberculosis immune protective outcomes, independent of T-cell immunity. Mucosal. Immunol. 2013. 6: 612-625.